Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Licenses Resolver from Rosetta

NEW YORK, Jan. 8-The Genomics Institute of the Novartis Research Foundation has licensed Rosetta's Resolver system, the company said today.

 

The system, which is scalable and customizable, will be used throughout the research foundation for bioinformatics and gene expression data organization.

 

Financial details of the agreement were not disclosed.

 

Rosetta is a bioinformatics subsidiary of Merck.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.